Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

Semaglutide- the active ingredient in 'Wegovy' and 'Ozempic'- may lower dementia risk in people with type 2 diabetes. | Drug ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...

New research reveals that sugar metabolism in brain cells may be a crucial defense against Alzheimer’s and related dementias.

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

A groundbreaking analysis from leading British universities has uncovered surprising links between everyday medications and ...

The AI tool, StateViewer, helped researchers identify a person’s dementia type in 88% of cases, according to results newly ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the brain. Researchers at Case Western Reserve University found that people ...